Asian Spectator

Men's Weekly

.

European Commission Approves Astellas' XOSPATA(TM) for Patient...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
SAN DIEGO, Oct. 30, 2019 /PRNewswire-AsiaNet/ -- Invivoscribe, Inc. announced today that the European Commission (EC) has approved the Astellas drug XOSPATA(TM) (gilteritinib) as a monotherapy for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with FLT3 ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Grup penyintas judi ‘online’: Ruang berbagi trauma dan doa untuk sembuh bersama

(Wisely/Shutterstock)● Grup Facebook menjadi ruang penyintas judi ‘online’ untuk mengatasi masalah kecanduan.● Melalui cerita personal, mereka membangun ingatan bersama seputar...

Aktivisme kelas menengah: Sempat redup, kini bangkit melawan rezim

Ilustrasi masyarakat kelas menengah mengikuti aksi demo menyampaikan aspirasi.Odua Images/Shutterstock● Pada gelombang demo Agustus lalu, kesadaran politik kelas menengah kembali bangkit setelah...

The story of MTV: The downfall of music disrupter

The Buggles' song "Video Killed the Radio Star" became the first video clip to be broadcast on MTV.Ilustrasi: Rino/The Conversation, CC BYWhen The Buggles’ music video “Video Killed the Ra...